IGF1 and prostate carcinoma: The inconsistent findings on the role of vitamin D in prostate cancer can be explained by the interference of insulin like growth factor (IGF) axis components, notoriously involved in prostate cancer etiology and progression [102], which may compromise the antiproliferative vitamin D action.